PT  - JOURNAL ARTICLE
AU  - Nalmpatian, Asmik
AU  - Heumann, Christian
AU  - Alkaya, Levent
AU  - Jackson, William
TI  - Local and global mortality experience: A novel hierarchical model for regional mortality risk
AID  - 10.1101/2024.10.17.24315673
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.10.17.24315673
4099  - http://medrxiv.org/content/early/2024/10/18/2024.10.17.24315673.short
4100  - http://medrxiv.org/content/early/2024/10/18/2024.10.17.24315673.full
AB  - Accurate mortality risk assessment is critical for decision-making in life insurance, healthcare, and public policy. Regional variability in mortality, driven by diverse local factors and inconsistent data availability, presents significant modeling challenges. This study introduces a novel hierarchical mortality risk model that integrates global and local data, enhancing regional mortality estimation across diverse regions. The proposed approach employs a two-stage process: first, a global Light Gradient Boosting Machine model is trained on globally shared features; second, region-specific models are developed to incorporate local characteristics. This framework outperforms both purely local models and standard imputation techniques, particularly in data-scarce regions, by leveraging global patterns to improve generalization. The model is computationally efficient, scalable, and robust in handling missing values, making it adaptable for other domains requiring integration of multi-regional data. This method enhances predictive accuracy across various regions and provides a more reliable approach for mortality risk estimation in data-scarce environments.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data for the study was collected in a pseudonymised form from eight different operating units of a global primary insurance company, each representing a distinct country.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data are owned by a third party (insurance company) and authors do not have permission to share the data.